TrademarkDir
THERACEUTICALS
DEAD

Serial Number

76016731

Owner

LONG LIFE MAXX, INC.

Attorney

ROGER P FUERY

First Use Date

Jul 20, 2000

Filing Date

Mar 8, 2000

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

THERACEUTICALS Trademark

Serial Number: 76016731 • Registration: 2521213

THERACEUTICALS is a trademark filed by LONG LIFE MAXX, INC. on March 8, 2000. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

LONG LIFE MAXX, INC. (37 trademarks)

6701 CENTER DRIVE WEST
LOS ANGELES, CA 90045

Entity Type: 03

PERPETUAL HEALTH, LLC (35 trademarks)

35 BARRACK ROAD
BELIZE CITY , BZ

Entity Type: 99

Braswell, A. Glenn (99 trademarks)

1500 OCEAN DRIVE, APT T-21
MIAMI, FL 33139

Entity Type: 01

Trademark Details

Filing Date

March 8, 2000

Registration Date

December 18, 2001

First Use Anywhere

July 20, 2000

First Use in Commerce

July 20, 2000

Published for Opposition

March 20, 2001

Cancellation Date

September 19, 2008

Goods & Services

Nutritional Supplements

Filing History

CANCELLED SEC. 8 (6-YR)
Sep 19, 2008 C8..
CASE FILE IN TICRS
Jan 3, 2007 CFIT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 17, 2003 TCCA
REGISTERED-PRINCIPAL REGISTER
Dec 18, 2001 R.PR
ASSIGNED TO EXAMINER
Aug 6, 2001 DOCK
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 31, 2001 CNPR
ASSIGNED TO EXAMINER
Jul 25, 2001 DOCK
STATEMENT OF USE PROCESSING COMPLETE
Jul 18, 2001 SUPC
USE AMENDMENT FILED
Jul 10, 2001 IUAF
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jun 12, 2001 NOAM
PUBLISHED FOR OPPOSITION
Mar 20, 2001 PUBO
NOTICE OF PUBLICATION
Mar 7, 2001 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 21, 2000 CNSA
NON-FINAL ACTION MAILED
Sep 12, 2000 CNRT
ASSIGNED TO EXAMINER
Sep 8, 2000 DOCK

Related Trademarks

More from this Owner

PROSTATAPLEX

PROSTATAPLEX

PROSTATAPLEX

PROSTATAPLEX

JOURNAL OF LONGEVITY

JOURNAL OF LONGEVITY

JOURNAL OF LONGEVITY

JOURNAL OF LONGEVITY

JOURNAL OF LONGEVITY

JOURNAL OF LONGEVITY

PLAQGARD

PLAQGARD